Skip to content
Peptide Biologicals

On desire, hunger and growth.

Why these appetites?

Peptide Biologicals began with a question about wanting: what changes when a molecule acts on a living system?

Appetite as a biological question

I like biological questions that refuse to stay in their allotted compartment. Desire sounds close to pleasure until an experiment separates them. Fullness sounds straightforward until someone describes losing interest in food altogether. Growth sounds like progress until the next question asks what grew and whether it helped.

Peptide Biologicals is an editorial site about ipamorelin, PT-141, semaglutide and tirzepatide. The name points towards the living responses around the molecules: a pituitary releasing a hormone, a change in desire, a shift in appetite, a clinical outcome. I think “enhancement” wastes a collection of good biological questions. The differences are the attraction.

The bremelanotide hamster experiment was an especially useful interruption. I had bundled wanting and enjoying together too easily. The human desire studies and the animal reward finding ask separate questions, and their answers can coexist. That is the kind of puzzle that earns a longer visit here.

The clinical boundary

These pages are for understanding published work, and they are not medical advice. A clinical assessment needs the person's health history and circumstances; a page about an experiment cannot supply that assessment. Peptide Biologicals offers no medicines, prescriptions or appointments. Treatment decisions belong with a licensed clinician who can assess the individual, including reasons to decline.

There are FDA-approved formulations of bremelanotide, semaglutide and tirzepatide for their specified indications; a compounded medicine has no FDA approval. Ipamorelin has no FDA approval. A chemical name or an appealing mechanism cannot resolve those clinical and regulatory differences.

A more exact biological claim

A correction is welcome when it makes a biological claim more exact: the wrong population, a changed outcome, a caution missing from a conclusion. The contact page gives the editorial address, and the reading list gathers the sources. A useful disagreement brings the question closer to the experiment. There is usually plenty left to be curious about after that.